Pascal Heberling

Cinven Group Ltd (Cinven Group) is a private equity firm founded in 1977. The firm is headquartered in London, United Kingdom.

Springer Nature Deutschland GmbH publishes scientific books, periodicals, and journals that focus on scientific and technical information. It also offers business services, seminars, trade fairs, conferences, as well as online publishing. The company was founded by Julius Springer on May 10, 1842 and is headquartered in Berlin, Germany.

Morfind 2025 Ltd. is a holding company, which provides infrastructure support services to the utility sector. The firm offers support services, working in partnership with a large number of commercial, public and utility organizations. The company was founded on September 17, 1996 is headquartered in Ilkley, the United Kingdom.

Spire Healthcare Holdings 3 Ltd. operates hospitals and provides private medical services. The company was founded on June 7, 2007 and is headquartered in London, the United Kingdon.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

BC Partners Ltd. (BC Partners) is an Independent Private Equity firm founded in 1986. BC Partners Ltd. is headquartered in London with additional offices in Hamburg, Paris and New York.

Travecta Therapeutics Pte Ltd. develops a novel chemistry platform for delivery of therapies to the brain. The company was founded by David L. Silver, Mahmood Ahmed, Michael Shleifer and Laurent Benissan and is headquartered in Singapore.

Abu Dhabi Investment Authority - private equity (ADIA) is a private equity arm of Abu Dhabi Investment Authority headquartered in Abu Dhabi, UAE. The firm began investing in private equity as early as in 1989 to diversify ADIA’s portfolio and to seek risk-adjusted returns that exceed those possible in the public equity markets.